Prof. Eloisa Jantus, Principal Investigator of the IDM’s Biocancer Group, participated as an invited speaker at the 8th Annual Congress of the International Society of Liquid Biopsy (ISLB 2026), held in Madrid from 7 to 9 November. The meeting brought together international experts to present the latest advances in liquid biopsy, emerging technologies and their applications in precision oncology.
In addition to her participation in the congress’s scientific programme, Eloisa Jantus and members of the Biocancer Group had the opportunity to exchange knowledge and ideas with internationally renowned researchers and professionals, strengthening the group’s collaborative network and exploring new research opportunities.
The Biocancer Group’s presence at ISLB 2026 reinforces the IDM’s commitment to excellence in biomedical research and to the development of innovative tools for cancer diagnosis and monitoring through liquid biopsy technologies.